Xeris Pharmaceuticals Inc Stock Forecast
Weaker technical forecast for Xeris Pharmaceuticals Inc as stock downgraded to Strong Sell Candidate.
(Updated on Apr 25, 2024)
The Xeris Pharmaceuticals Inc stock price fell by -3.41% on the last day (Thursday, 25th Apr 2024) from $1.76 to $1.70. During the last trading day the stock fluctuated 3.53% from a day low at $1.70 to a day high of $1.76. The price has fallen in 8 of the last 10 days and is down by -16.26% for this period. Volume has increased on the last day by 169 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 863 thousand shares were bought and sold for approximately $1.47 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -35.93% during the next 3 months and, with a 90% probability hold a price between $0.783 and $1.45 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
XERS Signals & Forecast
There are few to no technical positive signals at the moment. The Xeris Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.76 and $2.03. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, February 16, 2024, and so far it has fallen -47.20%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Xeris Pharmaceuticals Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Xeris Pharmaceuticals Inc stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0600 between high and low, or 3.53%. For the last week, the stock has had daily average volatility of 5.58%.
Xeris Pharmaceuticals Inc is oversold on RSI14 (17). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (XERS) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Xeris Pharmaceuticals Inc to open at $1.72, and during the day (based on 14 day Average True Range), to move between $1.59 and $1.81, which gives a possible trading interval of +/-$0.108 (+/-6.37%) up or down from last closing price. If Xeris Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 12.75% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $1.78, some $0.0800 (4.71%) from the current price of $1.70, our system finds the risk reward not very attractive.
Is Xeris Pharmaceuticals Inc stock A Buy?
Xeris Pharmaceuticals Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Current score: -5.284 Strong Sell Candidate Downgraded
Predicted Opening Price for Xeris Pharmaceuticals Inc of Friday, April 26, 2024
| Fair opening price April 26, 2024 | Current price |
|---|---|
| $1.72 ( 1.18%) | $1.70 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for XERS
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.78 | 4.71 % | |
| R2 | 1.76 | 3.36 % | ||
| R1 | 1.74 | 2.52 % | ||
| Current price: | 1.70 | |||
| Support | S1 | 1.70 | -0.172 % | |
| S2 | 1.68 | -1.00 % | ||
| S3 | 1.66 | -2.35 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.05 | 20.59 % | |
| R2 | 2.04 | 20.00 % | ||
| R1 | 1.78 | 4.71 % | ||
| Current price | 1.70 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Xeris Pharmaceuticals Inc Stock.
